¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
Orthobiologics Market Size, Share & Trends Analysis Report By Product (DBM, Allograft, BMP, Viscosupplementation), By Application (Spinal Fusion, Trauma Repair), By End Use, By Region, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå : 1772250
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,380,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,789,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,606,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå ±Ô¸ð´Â 2033³â±îÁö 103¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2033³â¿¡ °ÉÃÄ CAGR 4.74%·Î ¼ºÀåÇÒ °ÍÀ¸·Î °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è¿¡¼­ Á¤Çü¿Ü°ú ¼ö¼úÀÇ »ç·Ê°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. 2023³â ¹Ì±¹ Á¤Çü¿Ü°úÇÐȸ(AAOS) ¿¬·Ê ȸÀÇ¿¡¼­ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é Á¤Çü¿Ü°ú ÀÇ»çµéÀº Áõ°¡ÇÏ´Â °üÀý Àüġȯ¼ú(TJA) ¼ö¿ä¸¦ ÃæÁ·ÇÏ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÇコÄɾîÀÇ Áøº¸¿Í ȯÀÚÀÇ °á°ú¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö´Â °¡¿îµ¥, ¼¼°è °¢±¹ÀÇ Á¤ºÎ´Â ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇÑ ½ÃÃ¥À̳ª ÀÌ´Ï¼ÅÆ¼ºê¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Á¤Çü¿Ü°úÇÐȸ(AAOS)´Â ±Ù°ñ°Ý°è Ä¡·á¸¦ Åõ¸íÇÏ°í °úÇÐÀûÀ¸·Î °³¼±Çϱâ À§ÇØ ÃÖ¼±À» ´ÙÇϰí ÀÖ½À´Ï´Ù. 2020³â10 ¿ù, AAOS´Â À¥ »çÀÌÆ®¿¡ ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ´ë½Ã º¸µå¸¦ °³¼³ÇÏ¿© Á¤Çü¿Ü°ú Àǻ簡 ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º¸¦ »ç¿ëÇÏ´Â Ä¡·á¹ýÀÇ ½ÂÀÎ »óȲÀ» ÆÄ¾ÇÇÒ ¼öÀÖ°Ô Çß½À´Ï´Ù. AAOS Biologics InitiativeÀÇ ÀϺÎÀÌ¸ç ±Ù°ñ°Ý°è °Ç°­ Ä¿¹Â´ÏƼ¿¡ Áõ°Å ±â¹Ý ÁöħÀ» Á¦°øÇÏ´Â °ÍÀÔ´Ï´Ù.

¼¼°è ³ëÀÎÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ Á¤Çü¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2023³â Àεµ °í·ÉÈ­ º¸°í¼­¿¡ µû¸£¸é, Àεµ ³ëÀÎÀº ±Þ¼ÓÇÑ ¼Óµµ·Î Áõ°¡Çϰí ÀÖÀ¸¸ç 10³â µ¿¾È Áõ°¡À²Àº 41%ÀÔ´Ï´Ù. ³ëÀÎÀÌµÇ¸é °ñ´Ù°øÁõ, °ñ°üÀý¿°, °ñÀý µî ±ÙÀ°°ú »À¿¡ ¹®Á¦°¡ ¹ß»ýÇÒ °¡´É¼ºÀÌ ³ô¾ÆÁý´Ï´Ù.

°Ô´Ù°¡ ±³Åë»ç°í »ç·Ê Áõ°¡°¡ ½ÃÀåÀÇ ¼ºÀåÀ» º¸¿ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ µµ·Î±³Åë¾ÈÀü±¹(NHTSA) º¸°í¼­¿¡ µû¸£¸é, 2023³â »ó¹Ý±â¿¡ ¹ß»ýÇÑ ÀÚµ¿Â÷ »ç°í·Î ÀÎÇÑ »ç¸ÁÀÚ´Â 1¸¸ 9,515¸íÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ´Â 2022³â »ó¹Ý±âÀÇ ÃßÁ¤Ä¡ÀÎ 2¸¸ 190¸í¿¡ ºñÇØ ¾à 3.3% °¨¼ÒÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ¶ÇÇÑ 2023³â 1ºÐ±â, 2ºÐ±â ¸ðµÎ »ç¸ÁÀÚ ¼ö°¡ °¨¼ÒÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÀÌ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷Àº Á¦Ç° Çü¼º°ú ¸®Ä¡ÀÇ È®´ë¿¡ ÁßÁ¡À» µÎ°í Á¦ÈÞ, °ø±Þ °è¾à, ÆÄÆ®³Ê½Ê µîÀÇ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. 2023³â 9¿ù, HippoFi Inc.´Â Zimmer Biomet Holdings Inc.¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î°í »À ¼ºÀåÀ» À§ÇÑ »õ·Î¿î ÇÕ¼º ¹ÙÀÌ¿À Àç·á¸¦ ¼±º¸¿´½À´Ï´Ù. ÀÌ ¹ÙÀÌ¿À ¼ÒÀç´Â 2024³â¿¡ HippoFi Inc.ÀÇ »ý¹°ÇÐÀû ÀÚȸ»çÀÎ PUR Biologics¿¡ µû¶ó Ãâ½ÃµÉ ¿¹Á¤ÀÔ´Ï´Ù.

¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå ºÎ¹® ºÐ¼®, Á¦Ç°º°, 2021-2033³â

Á¦5Àå ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå ºÎ¹® ºÐ¼®, ¿ëµµº°, 2021-2033³â

Á¦6Àå ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå ºÎ¹® ºÐ¼®, ÃÖÁ¾ ¿ëµµº°, 2021-2033³â

Á¦7Àå ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º ½ÃÀå ºÎ¹® ºÐ¼®, Áö¿ªº°, Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, 2021-2033³â

Á¦8Àå °æÀï ±¸µµ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Orthobiologics Market Growth & Trends:

The global orthobiologics market size is estimated to reach USD 10.34 billion by 2033, expanding at a CAGR of 4.74% from 2025 to 2033, according to a new report by Grand View Research, Inc. Increasing cases of orthopedic surgeries across the globe is driving the demand for orthobiologics. A study presented at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) 2023, revealed that orthopedic surgeons would face a challenge in meeting the increasing demand for total joint arthroplasty (TJA). The study found that to keep up with the demand, surgeons will have to either double their TJA caseload or increase the number of surgeons by 10% every five years.

With an increasing focus on healthcare advancements and patient outcomes, governments worldwide are implementing policies and initiatives to foster the growth of orthobiologics. For instance, the American Academy of Orthopedic Surgeons (AAOS) is committed to improving musculoskeletal care in a transparent and scientific way. In October 2020, the AAOS launched the Biologics Dashboard on their website, which is designed to assist orthopedic surgeons in keeping track of the approval status of biologic-based interventions. This initiative is a part of the AAOS Biologics Initiative, which offers evidence-based guidance to the musculoskeletal health community. As part of this effort, the AAOS Board of Directors also revised two position statements related to biologics.

Increasing geriatric population across the globe is also anticipated to boost the demand for orthopedic surgeries. According to the India Ageing Report 2023, country's elderly population is growing at a rapid pace, with a decadal growth rate of 41%. By 2050, over 20% of India's population will be elderly citizens.As people age, they are more likely to experience issues with their muscles and bones, such as osteoporosis, osteoarthritis, and fractures. This results in a greater need for orthobiologics solutions.

Moreover, increasing cases of road accidents is anticipated to supplement the market growth. According to the National Highway Traffic Safety Administration report, there were an estimated 19,515 deaths in motor vehicle accidents during the first half of 2023. This represents a decrease of about 3.3% compared to the same period in the previous year, which had 20,190 fatalities. The report also shows that fatalities decreased during both the first and second quarters of 2023. Thus, the increasing number of injured populations is expected to increase the demand for orthobiologics.

The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing the product formation and reach. For instance, inSeptember 2023, HippoFi Inc. partnered with Zimmer Biomet Holdings Inc. to bring forth a synthetic biomaterial for bone growth. The biomaterial will be launched under HippoFi's biologic subsidiary, PUR Biologics in 2024.

Orthobiologics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Orthobiologics Market Variables, Trends & Scope

Chapter 4. Orthobiologics Market Segment Analysis, By Product, 2021-2033 (USD Million)

Chapter 5. Orthobiologics Market Segment Analysis, By Application, 2021-2033 (USD Million)

Chapter 6. Orthobiologics Market Segment Analysis, By End Use, 2021-2033 (USD Million)

Chapter 7. Orthobiologics Market Segment Analysis, By Region, By Product, By Application, By End Use, 2021- 2033 (USD Million)

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â